News/ News/ Oncology Sanofi takes a hit as hotly tipped breast cancer drug fails trial Phil Taylor amcenestrant, breast cancer, giridestrant, Roche, Sanofi, selective oestrogen receptor degrader 0 Comment Shares in Sanofi were on the slide this morning after the drugmaker revealed that one of its top Share X Sanofi takes a hit as hotly tipped breast cancer drug fails trial https://pharmaphorum.com/news/sanofi-takes-a-hit-as-hotly-tipped-breast-cancer-drug-fails-trial/